A Look into Nucleic Acid Isolation And Purification Industry……Deep Analysis…..


The global nucleic acid isolation and purification market size is expected to reach USD 4.2 billion by 2027, growing at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Nucleic acid isolation is the most basic step deployed in sequencing technologies. Increasing employment of next-generation sequencing (NGS) techniques along with the declining cost of genomic sequencing drives the market.
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.
Ongoing developments of automated nucleic acid extraction systems designed for high-throughput sample processing have significantly simplified the isolation of DNA and RNA, thereby providing lucrative avenues for market growth. These systems potentially reduce the labor costs and time, increase worker safety, laboratory efficiency, reproducibility, and quality of results.
The growing popularity of biopharmaceuticals has led to the development of nucleic acid-based products, such as DNA vaccines, small interfering RNA, and antisense oligonucleotides. These products are applied in therapeutic techniques, such as gene therapy and anti-sense technology, as a powerful tool for medical practitioners to treat cancer, genetic, and infectious diseases. This has boosted the adoption of DNA or RNA isolation techniques in the market.
To Request Sample Copy of this report, click the link:
Further key findings from the report suggest:
·         The instruments segment is expected to grow at a lucrative pace due to the advent of automated extraction systems resulting in high performance and lower cost for DNA extraction
·         DNA isolation methods accounted for the largest revenue share and are anticipated to witness the fastest progress rate due to ongoing discoveries of simple, rapid, and inexpensive methods
·         The high adoption rate of magnetic bead methods is attributive to its largest revenue share
·         This is because the method can isolate nucleic acids directly from the crude sample without much processing
·         This method is also expected to witness the fastest CAGR owing to the development of functionalized magnetic particles that have been incorporated in buffer systems to provide rapid and efficient extraction
·         Oncology application is projected to witness a lucrative growth rate as liquid biopsy techniques and patient-tailored therapies are gaining traction for cancer diagnosis
·         Hospitals and diagnostic centers accounted for the largest share in 2020, in terms of revenue
·         The high incidence rate of genetic and inherited diseases has increased the usage of nucleic acid isolation in early and accurate diagnosis of these conditions in hospitals
·         Better healthcare infrastructure, a substantial number of technology providers, and rapid adoption of NGS has driven the uptake of nucleic acid extraction products in North America at a large scale
·         Asia Pacific is anticipated to exhibit the fastest CAGR over the forecast period owing to significant public and private commitments towards genomics research and precision medicine, thereby prompting the adoption of isolation techniques
·         QIAGEN, Agilent Technologies, Danaher, Illumina, Roche, and Thermo Fisher are some key companies operating in the nucleic acid isolation and purification market.
The global nucleic acid isolation and purification market size was estimated at USD 2.4 billion in 2020 and is expected to register a CAGR of 7.2% over the forecast period. Several RNA species represent a wide, untapped class of biomolecules that play a vital role during disease progression. This has enhanced the pipeline for RNA therapeutics, which in turn, drives the application of nucleic acid isolation and purification protocols for drug development.
The isolation of nucleic acid is one of the essential achievements of modern science that brings advancement in human life. A rise in the utilization of high-throughput and automated extraction technologies has significantly simplified the DNA or RNA isolation processes. Besides, the expansion of next-generation sequencing (NGS) technologies drives the market for nucleic acid isolation and purification, because DNA and RNA purification play a critical role in obtaining accurate NGS data.
Nucleic acid-based diagnostics are extensively employed in laboratory settings to diagnose a wide range of medical conditions. Increasing prevalence of cancer, infectious diseases, genetic disorders, and neglected tropical diseases surge the demand for isolation of DNA or RNA for the nucleic acid-based diagnostics, hence providinghigh-value avenues in the market for nucleic acid isolation and purification.
The continuous advancements in agriculture science and technology have considerably revolutionized the genetically modified (GM) crop production. The introduction of multiple traits in GM crops through genetic engineering technologies provide herbicide tolerance, drought tolerance, and insect resistance to crops. These processes significantly increase the implementation of DNA extraction procedures in GM crop production.
Browse Press Release of this report:
Grand View Research has segmented the global nucleic acid isolation and purification market on the basis of product, type, method, application, end use:
Nucleic Acid Isolation And Purification Product Outlook (Revenue, USD Million, 2016 - 2027)
·         Kits & Reagents
·         Instruments
Nucleic Acid Isolation And Purification Type Outlook (Revenue, USD Million, 2016 - 2027)
·         DNA Isolation & Purification
o    Genomic DNA
o    Plasmid DNA
o    Viral DNA
o    Other Types
·         RNA Isolation & Purification
o    miRNA
o    mRNA
o    Total RNA
o    Other Types
Nucleic Acid Isolation And Purification Method Outlook (Revenue, USD Million, 2016 - 2027)
·         Column-based
·         Magnetic Bead-based
·         Reagent-based
·         Other Methods
Nucleic Acid Isolation And Purification Application Outlook (Revenue, USD Million, 2016 - 2027)
·         Oncology
·         Precision Medicine
·         Diagnostics
·         Drug Discovery & Development
·         Agriculture and Animal Research
·         Other Applications
Nucleic Acid Isolation And Purification End-Use Outlook (Revenue, USD Million, 2016 - 2027)
·         Academic Research Institutes
·         Pharmaceutical & Biotechnology Companies
·         Contract Research Organizations
·         Hospitals and Diagnostic Centers
·         Other End-use
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.



Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..